Reuters logo
BRIEF-Acelrx pharmaceuticals says co entered into 2nd amendment with Patheon Pharma
August 23, 2017 / 10:33 AM / a month ago

BRIEF-Acelrx pharmaceuticals says co entered into 2nd amendment with Patheon Pharma

Aug 23 (Reuters) - Acelrx Pharmaceuticals Inc

* Acelrx Pharmaceuticals - on August 22, co entered second amendment to manufacturing services deal effective as of august 4, 2017, with Patheon Pharma

* Acelrx pharmaceuticals - amendment related to manufacture of Sufentanil Sublingual tablets for use with co's product candidate, DSUVIA - SEC Filing Source text: (bit.ly/2w2uxmi) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below